Filters
reset allOther countries
Results: 1 to 12 of 12
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Centogene US, LLC - The Rare Disease Company United States | 406 | 414 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
ATP5F1E - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
ATP5F1E - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics United States | 290 | 251 |
|
Mitochondrial Complex V Deficiency Panel (Nuclear Genes) PreventionGenetics United States | 4 | 4 |
|
Mitochondrial Complex V Deficiency via the ATP5F1E (ATP5E) Gene PreventionGenetics United States | 1 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
ATP5E Deletion/Duplication Analysis Baylor Genetics United States | 1 | 1 |
|
ATP5E Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 1 | 1 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.